IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,058 | -45.8% | 7,187 | -35.5% | 0.01% | -42.9% |
| Q2 2023 | $210,382 | -1.2% | 11,149 | -75.0% | 0.01% | -12.5% |
| Q3 2022 | $213,000 | +150.6% | 44,600 | +323.4% | 0.02% | +100.0% |
| Q1 2021 | $85,000 | – | 10,533 | +10433.0% | 0.01% | – |
| Q4 2020 | $0 | -100.0% | 100 | -89.1% | 0.00% | -100.0% |
| Q1 2020 | $3,000 | +200.0% | 914 | +41.3% | 0.00% | – |
| Q3 2019 | $1,000 | -99.4% | 647 | -96.1% | 0.00% | -100.0% |
| Q3 2018 | $158,000 | +69.9% | 16,789 | +75.4% | 0.01% | +83.3% |
| Q2 2018 | $93,000 | +8.1% | 9,573 | +15.8% | 0.01% | -14.3% |
| Q1 2018 | $86,000 | +437.5% | 8,264 | +334.9% | 0.01% | +133.3% |
| Q1 2016 | $16,000 | -69.8% | 1,900 | -66.0% | 0.00% | -66.7% |
| Q3 2015 | $53,000 | +194.4% | 5,595 | +343.0% | 0.01% | +200.0% |
| Q2 2015 | $18,000 | +1700.0% | 1,263 | +321.0% | 0.00% | – |
| Q4 2014 | $1,000 | -99.6% | 300 | -98.7% | 0.00% | -100.0% |
| Q3 2014 | $251,000 | +286.2% | 23,716 | +331.2% | 0.04% | +250.0% |
| Q2 2014 | $65,000 | +182.6% | 5,500 | +243.8% | 0.01% | +100.0% |
| Q1 2014 | $23,000 | -55.8% | 1,600 | -55.6% | 0.01% | -80.0% |
| Q4 2013 | $52,000 | – | 3,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |